Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
17.47
+0.74 (4.42%)
Nov 22, 2024, 4:00 PM EST - Market closed
CRBP Employees
Corbus Pharmaceuticals Holdings had 19 employees as of December 31, 2023. The number of employees decreased by 14 or -42.42% compared to the previous year.
Employees
19
Change (1Y)
-14
Growth (1Y)
-42.42%
Revenue / Employee
n/a
Profits / Employee
-$2,036,859
Market Cap
212.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
ADC Therapeutics | 274 |
Editas Medicine | 265 |
Personalis | 225 |
Enanta Pharmaceuticals | 145 |
Profound Medical | 131 |
Lexeo Therapeutics | 58 |
Orchestra BioMed Holdings | 56 |
CRBP News
- 11 days ago - Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha
- 24 days ago - Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 5 weeks ago - Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) - GlobeNewsWire
- 2 months ago - Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit - GlobeNewsWire
- 2 months ago - Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga
- 3 months ago - Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say - Market Watch
- 3 months ago - Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - GlobeNewsWire
- 3 months ago - Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire